Validation criteria for nucleic acid amplification techniques for bacterial infections

Area of Science:

• Microbiology
• Molecular Biology
• Infectious Diseases

Background:

• Nucleic acid techniques (NATs), including species-specific and universal polymerase chain reactions (PCRs), are increasingly utilized for bacterial infection diagnosis.
• Universal PCR assays, while powerful, face limitations such as reduced sensitivity compared to species-specific PCR and susceptibility to DNA contamination.

Purpose of the Study:

• To highlight the critical need for comprehensive validation of NATs in diagnosing bacterial infections.
• To discuss the essential components and challenges in validating NATs for clinical application.

Main Methods:

• Validation encompasses rigorous procedures including sampling, DNA extraction, amplification, result visualization, asepsis measures, and control inclusion (positive, negative, reagent, inhibition).
• Methods involve optimizing DNA release from bacterial cells, repeating amplification, and comparing NAT results with conventional microbiological methods and clinical evidence.

Main Results:

• Universal PCR sensitivity is lower than species-specific PCR.
• Contamination of samples and reagents with extraneous DNA is a significant challenge.
• Validation of NATs in clinical diagnosis presents ongoing difficulties.

Conclusions:

• NATs, particularly universal PCR, require meticulous validation to be effective diagnostic tools.
• Due to inherent limitations, NATs should be considered adjuncts to, not replacements for, conventional culturing techniques in selected cases of bacterial infection diagnosis.